IDEXX Laboratories Inc IDXX

NASDAQ US Health Care
$559.07 ▲ +0.05% (+$0.27)
Index member: S&P 500
📅 Earnings This Week
Open $553.08
Prev Close $558.80
Day Range $549.33 – $563.05
52W Range $518.55 – $769.98
Market Cap $44.10B
P/E (TTM) 40.04
Beta 1.55
EPS (TTM) $13.59

📋 Company Profile

IndustryHealth Care
CountryUS
ExchangeNASDAQ NMS - GLOBAL MARKET
CurrencyUSD
IPO Date1991-06-21
Shares Out.78,880,000
Websiteidexx.com/ ↗
Phone12075560300
Employees11,000
Revenue$1.14B
Gross Profit$722.7M
Net Income$278.4M
Free Cash Flow$1.08B
Total Assets$3.39B
Total Liabilities$1.83B
Equity$1.56B
About IDEXX Laboratories Inc

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.

IDEXX Laboratories Inc is a publicly traded company under the ticker symbol IDXX on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.

📊 Analyst Ratings

22 analysts (2026-07-01)

Strong Buy 7
Buy 7
Hold 8

📰 Latest News for IDXX

👥 Related Stocks